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Abstract
Background: The impact of retinal pathology detected by high-resolution imaging on vision remains largely unexplored.
Therefore, the aim of the study was to achieve high-resolution structure-function correlation of the human macula in vivo.
Methodology/Principal Findings: To obtain high-resolution tomographic and topographic images of the macula spectral-
domain optical coherence tomography (SD-OCT) and confocal scanning laser ophthalmoscopy (cSLO), respectively, were
used. Functional mapping of the macula was obtained by using fundus-controlled microperimetry. Custom software
allowed for co-registration of the fundus mapped microperimetry coordinates with both SD-OCT and cSLO datasets. The
method was applied in a cross-sectional observational study of retinal diseases and in a clinical trial investigating the
effectiveness of intravitreal ranibizumab in macular telangietasia type 2. There was a significant relationship between outer
retinal thickness and retinal sensitivity (p,0.001) and neurodegeneration leaving less than about 50 mm of parafoveal outer
retinal thickness completely abolished light sensitivity. In contrast, functional preservation was found if neurodegeneration
spared the photoreceptors, but caused quite extensive disruption of the inner retina. Longitudinal data revealed that small
lesions affecting the photoreceptor layer typically precede functional detection but later cause severe loss of light
sensitivity. Ranibizumab was shown to be ineffective to prevent such functional loss in macular telangietasia type 2.
Conclusions/Significance: Since there is a general need for efficient monitoring of the effectiveness of therapy in
neurodegenerative diseases of the retina and since SD-OCT imaging is becoming more widely available, surrogate
endpoints derived from such structure-function correlation may become highly relevant in future clinical trials.
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Introduction
The human central retina, the macula, is both the anatomical
structure responsible for fine detail vision and subject to disease
causing irreversible blindness. Histology has long been the only
means to investigate retinal morphology in health and disease, and
thus, the functional impact of the pathologic changes of the retina
largely remained unknown.
Recent developments in high-resolution in vivo imaging of the
central retina such as spectral domain optical coherence
tomography (SD-OCT) and confocal scanning laser ophthalmos-
copy (cSLO) promise to enhance early diagnosis and objective
evaluation of macular diseases. High-resolution OCT generates
tomographic images similar to tissue sections and permits
visualization of retinal morphology that had previously only been
possible with histopathology [1,2]. cSLO imaging provides
detailed and high-contrast topographic images similar to photog-
raphy and has become a powerful tool to monitor atrophic and
dystrophic retinal diseases [3]. Investigating treatment effective-
ness by high-resolution imaging has very recently gained
tremendous importance because retinal pharmacotherapy, espe-
cially vascular endothelial growth factor A (VEGF-A) inhibition,
has revolutionized therapy of macular diseases [4,5,6,7,8].
However, there remains a fundamental problem because the
functional consequences of abnormalities detected with such high-
resolution imaging technology are unclear. Therapeutic interven-
tion in order to modify the retinal lesions detected with high-
resolution imaging may only be justified if these abnormalities
indeed cause functional loss.
Fundus-controlled microperimetry is a functional test allowing
analysis of retinal sensitivity with a high spatial resolution [9]. It
differs from standard perimetry techniques in that it is indepen-
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achieved by controlled projection of the test stimuli in constant
topographic relation to retinal landmarks. An exact overlay of such
functional mapping with high-resolution images of the retina
would reveal the functional impact of microstructural alterations in
vivo. Although simultaneous topographic (cSLO imaging) and
tomographic (SD-OCT) retinal imaging in exact spatial correla-
tion has recently been developed in one instrument [10], high-
resolution structure-function correlation has not yet been
achieved. Therefore, we aimed at a co-registration of quasi-
histological and high-resolution functional mapping of the central
retina. We studied the impact of neurodegenerative structural
changes on visual function and investigated how this technique
may add further insight into the outcome of pharmacological
intervention.
The data show that retinal in vivo imaging with histology-like
resolution and its exact co-registration with functional high-
resolution mapping of the macula is now feasible. A method
(MultiModalMapper) was developed that allows for accurate co-
registration of the coordinate systems of fundus-controlled micro-
perimetry, high-resolution 3D-OCT datasets and cSLO images. By
translating the method into a clinical setting, the proof of concept is
provided for the ability of the technique to generate unprecedented
information on the functional impact of retinal pathology. The
technique may not only increase the reliability of the interpretation
of findingsrevealed bydifferent modesofretinal imaging. Itwill also
allow the use of high-resolution imaging techniques for estimating
functional consequences of morphological alterations and assess
treatment benefits in a more objective way.
Results
Accuracy of Co-registration of Functional Mapping and
Retinal Imaging
The quality of co-registration of retinal sensitivity maps and
imaging (both tomographic and topographic) data is exemplified
for the optic disc in a normal subject (Fig. 1). The optic disc area
represents the physiologic blind spot which can be mapped using
microperimetry as previously shown [9]. There was accurate co-
registration showing that within the blind spot, there was no light
sensitivity detectable, whereas just outside the optic disc, normal
retinal sensitivity was measured. This correlated both topograph-
ically with the retinal area outside the optic disc on infrared
reflectance image and with a normal outer retinal morphology as
imaged by SD-OCT (Fig. 1, inlay). Structure-function correlation
of the macula in a normal subject is shown in Fig. 2, (left column)
and in the Video S1.
Structure-Function Correlation in Macular Telangiectasia
Type 2: Cross-sectional Data
In macular disease, well-defined features of structure-function
correlation are exemplified in macular telangiectasia type 2. This
neurodegenerative disease shares many similarities with age-related
macular degeneration and diabetic retinopathy, together by far the
most common causes of blindness in the western world. Well-
demarcated paracentral visual field defects and characteristic
neurodegenerative alterations of the macula are typically observed
[11,12,13]. The latter may appear as tissue defects apparent on SD-
OCT assessment within both the inner and outer neurosensory
retina. Investigating a study population of 33 comprehensively
phenotypedpatients,weobserved ageneralpattern:While structural
damage to the outer retina (photoreceptor layers) was accompanied
by a loss of retinal sensitivity as detected by microperimetry (Fig. 2,
right column; Video S2), similar structural changes limited to the
inner retina (proximal to the photoreceptor layer) typically showed
preserved function (Fig. 2, middle column; Video S2).
Fixation stability measurements demonstrated that patients with
macular telangiectasia type 2 (n=31) had excellent fixation
stability (mean BCEA, 1907 minarc
2), although having profound
paracentral sensitivity loss (see Fig. S1). Consequently, there was
no significant difference of fixation stability when compared to a
group of normal subjects (n=15; alpha p=0.37) corroborating
earlier reports [14] and precluding major effects of eye movements
on data accuracy.
Quantitative analysis revealed that there was a significant
relationship between the outer retinal thickness and retinal
sensitivity (p,0.001; Fig. 3). The data suggest a biological
threshold of about 40–60 mm residual thickness of the parafoveal
(1–2 degrees eccentric to the foveal center) photoreceptor layer:
Neurodegeneration leaving more than about 50 mm outer retinal
thickness would be associated with residual light sensitivity,
whereas degeneration beyond this threshold may completely
abolish retinal light sensitivity.
Structure-Function Correlation in Other Retinal
Dystrophies
The wider applicability of these findings is demonstrated in
patients with other neurodegenerative diseases of the retina. Fig. 4
presents two patients suffering from two different monogenic retinal
dystrophies.The upperpanels(A,B) displaysthemaculaof a 17 year
old patient with X-linked retinoschisis (OMIM 312700) carrying a
point mutation in exon 4 of the RS1 gene (c.293C.A). In this
disease,itwasrecentlyshown thatthemajorpathologicalalterations
of the central retina occur mainly proximal to the photoreceptor
layer [15]. In line with these findings, SD-OCT shows extensive
inner retinal alterations, leaving an outer retinal thickness of 90–
100 mm. Again, there was remarkable functional preservation:
Figure 1. Ability of co-registration using the MultiModalMap-
per software to exactly map functional testing on anatomical
recordings in a normal subject. The optic nerve head is the
anatomical correlate for the physiological blind spot in the visual field.
The hollow red square represents the brightest stimulus using
microperimetry and was not detected by the subject (absolute
scotoma) when projected onto the optic nerve head. In contrast, a
much dimmer testing point (green square, 18dB decreased light
intensity compared to the brightest stimulus) projected just outside the
optic nerve area head was detected by the subject and shows normal
light sensitivity. An overlay with the SD-OCT scan (inset, framed in
white) shows the normal retinal layers within the area bordering the
optic nerve head.
doi:10.1371/journal.pone.0012864.g001
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for a relative scotoma at the foveal center. The lower panels of
Fig. 4(C,D) illustrates findings in a 33 year old female patient
suffering from Usher syndrome 2A (OMIM 608400) carrying a
mutation in exon 13 of the USH2A gene (c.2299delG). Usher
syndrome is the mostfrequent cause of inherited combined deafness
and blindness. The characteristic photoreceptor dystrophy is
illustrated on the SD-OCT scan through the fovea: the parafoveal
ring of slightly increased autofluorescence delineates a central area
of largely preserved retinal function and anatomy from a more
eccentric area with marked loss of function and outer retinal
thinning. Again, photoreceptor layer thickness of 50 mmo rl e s sw a s
associated with an absolute scotoma. The structure-function
correlations in these patients with X-linked retinoschisis and Usher
syndrome 2A corroborate the findings in macular telangiectasia
type 2, namely functional preservation if neurodegeneration spares
the photoreceptors, but a strong functional impact if neurodegen-
eration affects the outer retina.
Structure-Function Correlation in an Interventional Trial:
Ranibizumab to Treat Macular Telangiectasia Type 2
Longitudinal observations of the association between morpho-
logical abnormalities derived from high-resolution retinal imaging
and visual function was investigated in a prospective interventional
trial (RAMA trial, see Methods). The study eye of ten patients with
macular telangiectasia type 2 received monthly intravitreal
injections of 0.5 mg ranibizumab to neutralize VEGF-A over a
study period of 12 months, while the other affected eye served as
control. Despite a clear effect on retinal morphology (see Fig. S2),
there was no significant effect on the primary endpoint, change in
visual acuity after 12 months (study eyes: +3.5 letters, SD 65.4,
p=0.07; fellow eyes: +3.7 letters, SD 65.9, p=0.08). In contrast,
analysis of the mean change in paracentral retinal sensitivity from
baseline to 12 months using microperimetry revealed functional
loss in the study eye (22.3 dB; SD 2.4; p=0.01) and in the fellow
eye (21.3 dB; SD 1.6; p=0.03). As exemplified in Fig. 5, high-
resolution analysis of the structure-function correlation revealed
progressive tissue loss within the photoreceptor layer as the
morphological correlate of the decrease in retinal sensitivity.
Notably, the example illustrates that minimal outer retinal damage
(diameter of about 100 mm) six months after the baseline visit was
not detected by microperimetry. After another six months, the
enlarged pathology (diameter of about 680 mm) resulted in
pronounced paracentral sensitivity loss that left visual acuity
unaffected. This pattern of detecting minimal morphologic
abnormalities preceding the detection of initial functional defects
was consistently observed in the study population.
Discussion
In previous attempts to correlate retinal function and structure,
visual acuity was correlated with central retinal thickness derived
from OCT measurements, e.g. in diabetic macular edema.
However, the relationship was found to be poor and it was
concluded that retinal thickness is a poor surrogate for visual
Figure 2. Correlation of topographic and tomographic retinal imaging with functional mapping. Threshold values of retinal sensitivity
derived from microperimetry are presented according to the scale below panel i) in 2 dB steps. Normal sensitivity is indicated by green colour, and
decreased sensitivity is indicated by red colour; open rectangles demonstrate absolute defects (as defined in Ref [11]). The first column illustrates findings
inanormalsubject,themiddleandrightcolumnintwopatientswithmaculartelangiectasiatype2.Thefirstrowshowsfunctionalmapssuperimposedon
near-infrared confocal scanning laser ophthalmoscopy (cSLO) images of the central retina. The second and third row (d–i) show the functional maps
superimposedontheback-tiltedcSLOimagesanda high-resolutionspectral-domainoptical coherencetomography (SD-OCT)scan.Thelowerpanels (g-i)
show enlarged cut-outs of the middle row (d–f). For the normal subject, selected anatomical layers of the retina are indicated for orientation on the left-
handsideofpanel g(INL:inner nuclearlayer; ONL:outer nuclearlayer; IS/OS:junctionofthe innerandouter photoreceptor segment;RPE:retinal pigment
epithelium).Thetissuedefectwithinthe innerretina(e,h)isassociatedwitha normalretinallightsensitivity(greensquares),whereasdamagetotheouter
retina (the photoreceptor layers) was accompanied by a strong loss of retinal sensitivity (red filled and red open squares; f,i).
doi:10.1371/journal.pone.0012864.g002
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technique, it was recently shown that the correlation between
visual acuity and specifically the outer retinal thickness is
considerably stronger than for full macular thickness suggesting
that detailed image analysis is essential to find a correlation [17].
Since visual acuity testing exclusively reveals foveal function but
does not provide a functional map of the retina, kinetic or
automated static perimetry has been used to reveal and quantify
functional defects of the visual field. Using these techniques, there
was a consistent relationship between the thickness of the
photoreceptor layers as determined by SD-OCT and retinal
sensitivity in retinitis pigmentosa, which is genetically heteroge-
neous group of photoreceptor degeneration [18,19].
However, these techniques do not provide an accurate
correlation between retinal structural pathology and functional
defects. Co-registration of microperimetry-, cSLO- and SD-OCT
datasets now provides an exact overlay of functional and structural
exams and reveals the functional impact of microstructural
alterations in vivo.
The cross sectional data show that there can be remarkable
functional preservation if the pathology spares the outer
neurosensory retina that accommodates the process of photo-
transduction, highlighting the eminent importance of photorecep-
tor layer integrity for maintaining visual function [18,19,20].
Notably, anti-VEGF-A therapy appeared to be ineffective to
prevent such functional loss in the longitudinal interventional
clinical trial. Actually, recent studies showed that VEGF-inhibition
can cause dysfunction and damage of the murine retina [21,22].
There has long been the fundamental question about whether
morphological changes in the neurosensory system precede
functional alterations or vice versa. Our data may suggest that
high-resolution imaging can detect very early retinal pathology
before its progression causes functional loss as detected by
functional mapping. It cannot unequivocally be decided whether
there are compensatory functional mechanisms when there are
sufficiently small morphological defects or whether microperime-
try is methodologically limited to detect the earliest functional
deficits, or both. In either case, high-resolution OCT appears
superior to functional mapping to detect relevant damage of the
central retina early in the disease process.
cSLO topographic imaging of the retina provides approximate-
ly 15 mm transversal resolution [23]. However, if aberrations are
compensated using adaptive optics, the transversal resolution of a
cSLO could be improved to less than 3 mm [24]. Zawadzki et al.
using spectral/Fourier domain detection and a closed loop
adaptive optics system achieved improved lateral resolution (,
4 mm) of retinal images, while maintaining the high axial
resolution (,6 mm) of OCT. Their instrument enabled the
three-dimensional visualization of different retinal structures,
e.g., microscopic blood vessels, and an en face view of the cone
photoreceptor mosaic [25]. Simultaneous cSLO and SD-OCT in
combination with adaptive optics may have the potential to
provide researchers and clinicians with near cellular-resolution
information on intraretinal morphology [2].
Although there has been progress correlating single cone
photoreceptors to the response of central visual neurons
anatomical maps [26] or relating retinal nerve fiber layer
distribution with visual fields in glaucoma [27], this is the first
report of a high-resolution structure-function correlation of
pathology within the central human retina. Such a methodology
is capable of revealing an unprecedented pathophysiological
context in retinal disease that is highly relevant for therapeutic
decision. In diseases such as X-linked retinoschisis where gene
therapy has been shown to work in animal models
[28,29,30,31,32,33], future therapeutic trials should aim to
preserve the outer retinal morphology that, if still intact, may
provide the patient with relatively good visual function.
A robust correlation between structural abnormalities of the
retina and functional deficits may have to be established for every
individual disease entity. For enhanced S-cone syndrome due to
mutations in the NR2E3 gene, it has recently been shown that
both increased and decreased retinal thickness are associated with
retinal sensitivity loss [34]. While an increase in retinal thickness
was due to a foveal schisis, a decrease was due to neurodegen-
eration of the retina. This study shows that retinal thickness per se
is a poor predictor of retinal function and it underscores the
importance to correlate individual retinal layers with retinal
function as performed in our study.
Current clinical practice emphasizes the development of
techniques to diagnose disease in its early stages, when treatment
is most effective and irreversible damage can be prevented or
delayed. There is a strong need to define surrogate endpoints
which may serve as a substitute for a true clinical endpoint (such as
functional loss) but are more efficient [35,36]. Since our data
indicate consistent associations between high-resolution imaging
and visual function and since such imaging techniques are
becoming more widely available, high-resolution imaging of the
retina may have a high potential to serve as surrogate endpoints in
future clinical trials.
Materials and Methods
Patients
The prospective observational study received ethical approval
by the local institutional review board (IRB). Approval for the
prospective interventional clinical trial (see below) was obtained
from the IRB, the European Medicines Agency (EMEA, London,
Figure 3. Correlation of retinal light sensitivity (in dB, x-axis)
and outer retinal thickness (in mm; y-axis). The cross table
compares positive sensitivity and thickness values (i.e. detectable outer
retina on SD-OCT images and measurable light sensitivity) with those
having a value of zero. There was a significant relationship between the
outer retinal thickness and retinal sensitivity (p,0.001; two-sided Fisher
exact test of significance). A clustering of data at zero (n=28) implicates
that a complete loss of the outer nuclear layer was associated with an
absolute scotoma, i.e. a complete loss of retinal light sensitivity. When
omitting this subset in a sub-analysis, outer retinal thickness and retinal
sensitivity still showed a significant correlation (r=0.66; p,0.001;
Spearman-Rho; positive scatter plot).
doi:10.1371/journal.pone.0012864.g003
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Institut, Berlin, Germany). The diagnosis of macular telangiectasia
type 2 was based on typical findings on fluorescein angiography
and ophthalmoscopy as described by Gass and Blodi [37].
Additionally, all patients showed a macular pigment distribution
and alterations on OCT characteristic for the disease
[12,13,38,39]. Thirty-three patients (66 eyes) were enrolled in
the study. Three eyes were excluded, either due to unavailability of
a microperimetric exam (n=1) or due to the presence of a
neovascular membrane (n=2), leaving 63 eyes for analysis.
Individual patients with retinal dystrophies were selected from a
comprehensive cross-sectional study of high-resolution retinal
imaging in monogenic retinal dystrophies. The principles of the
declaration of Helsinki and good clinical practice guidelines were
followed. Patients provided written informed consent for study
participation.
Visual acuity testing
Best corrected distance visual acuity was measured by standard
Early Treatment Diabetic Retinopathy Study (ETDRS) protocols
with a distance chart transilluminated with a chart illuminator
(Lighthouse International, New York, NY).
Microperimetry
Fundus-controlled microperimetry (MP1, Nidek Technologies,
Padova, Italy) was performed as described previously [11]. Briefly,
a tracking software uses anatomic landmarks with high contrast,
such as retinal vessels, to record eye movements during the
examination. This information is used to project the test stimuli
(Goldman III size, 100 ms projection time, 4-2 staircase test-
strategy) in spatial correlation to anatomic landmarks, indepen-
dent from eye movements. A predefined automatic 16u macula test
pattern with a red cross (2u in diameter) as fixation target was used.
In patients with macular telangiectasia type 2, additional stimuli
were placed within the macular area between the predefined
testing points. This resulted in a maximum of 45 testing points
(each 1 degree apart) covering an area of 8 degrees horizontally
and 4 degrees vertically centered on the foveal centre. Test points
revealing an absolute scotoma as well as individual testing points
with questionable validity were retested manually by the examiner.
Figure 4. Structure-function correlation of the central retina in a patient with X-linked retinoschisis (upper panels) and a patient
with Usher syndrome 2A (lower panels). Retinal sensitivity of the individual testing points is colour coded as in Fig. 2. Upper panels: The
functional map derived from microperimetry is superimposed on a cSLO infrared reflectance image (A) and a 15 deg SD-OCT scan (B). Retinal
sensitivity is largely preserved despite a splitting of the neurosensory retina mainly confined to layers proximal to the photoreceptors. Only the most
distinct alterations result in a relative scotoma (10 dB decreased light intensity compared to the brightest stimulus). The thickness of the
corresponding photoreceptor layer (double headed arrow) is about 100 mm. Lower panels: The functional map superimposed on a cSLO fundus
autofluorescence image (C) and a cutout of a 30 deg SD-OCT scan (D). Retinal sensitivity is relatively preserved within the parafoveal ring of increased
autofluorescence. Peripheral to this ring, the photoreceptor layer reveals a marked thinning. Thickness values at the location of the three perimetric
testing points marked with double headed arrows (from left to right) are ,110 mm, ,70 mm and ,50 mm.
doi:10.1371/journal.pone.0012864.g004
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SD-OCT was performed with the Spectralis HRA+OCT
(Heidelberg Engineering, Heidelberg, Germany). A second laser
scanning system (confocal scanning laser ophthalmoscope, cSLO)
operates simultaneously and allows recordings of topographic
confocal images, including modalities such as near-infrared
reflectance, fundus autofluorescence or angiography. The position
of the SD-OCT scan on the fundus is in exact anatomical
correlation to the topographic cSLO image. Stable positioning
despite eye movements is ensured by an eye tracking system that
continuously recognizes eye movements using landmarks with
sharp contrast boundaries on cSLO images. Averaging of multiple
single SD-OCT scans at the same position leads to an increased
signal to noise ratio in the generated mean images. The SD-OCT
system works with an average wavelength of 870 nm and has an
axial resolution of 7 mm and a lateral optical resolution of 14 mm
[10].
Co-registration of functional testing and structural
imaging
A custom-made software tool (MultiModalMapper) allows for
co-registration of the coordinate systems of microperimetry and
OCT datasets. Microperimetry data as well as SD-OCT data are
fundus-related and can be mapped by registering the fundus
images of both devices. Microperimety data (Nidek MP1) consists
of 2 files that can be imported into the software tool. One file
contains the actual perimetry data as well as mapping information
for the second file, the fundus image. OCT data can be exported
from the EyeExplorer (Heidelberg Engineering, Heidelberg,
Germany) as binary VOL file containing B-scans, cSLO and B-
scan segmentation data (optional). The binary file structure can be
imported and selected content can be visualized (cSLO for
registration; cSLO and B-Scans for 3D view).
The affine transformation model needed to map microperime-
try data (source coordinate system) on OCT data (target
Figure 5. Longitudinal structure-function correlation in macular disease. Retinal sensitivity of the individual testing points is colour coded
as in Fig. 2. The 54 year old female patient was treated with 0.5 mg intravitreal ranibizumab in monthly follow-up (f/u) intervals. Shown are images
obtained at baseline (left column), after 6 (middle column) and 12 monthly treatments with ranibizumab (right column). The first row shows
functional maps (colour coded as in Fig. 1) superimposed on late-phase fluorescein angiography cSLO images. The patient shows leakage of dye in
the macula with a maximum at the paracentral temporal area at baseline. Treatment with monthly ranibizumab considerably reduced such leakage
(panels b, c). However, the patient developed loss of retinal sensitivity and showed an absolute scotoma (open red rectangles) at the completion of
the study period (c). The second and third row (enlarged cut-outs of the middle row) show corresponding SD-OCT images superimposed on back-
tilted infrared cSLO images and the same functional map as shown in the upper row. At baseline, the patient shows considerable abnormality of inner
retinal anatomy (hyporeflective tissue defect; panels d, g). Retinal sensitivity was normal. After six months of treatment, outer retina abnormalities
developed affecting the photoreceptor layer (panels e, h). This alteration measuring about 100 mm appeared to be too small to be detected by
fundus-controlled microperimetry. However, after 12 months of treatment, damage of the outer retina was associated with a strong loss of retinal
sensitivity (f, i). Visual acuity at baseline was 20/40 and remained unchanged over the study period despite such pronounced loss of paracentral visual
function.
doi:10.1371/journal.pone.0012864.g005
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on both fundus images. Landmark selection is done manually since
the quality of the perimetry fundus image turned out to be
insufficient for automatic approaches. The result of the co-
registration process is visualized immediately as overlay image to
allow for adjustment by moving or adding additional landmarks.
The applied affine transformation model accounts for adjustable
radial lens distortion factors for both the source and the target
coordinate system [40]. At least 3 landmarks are needed to solve
the linear system for the affine transformation.
The transformed microperimetry data can then be visualized as
an additional layer within the 3D view of the SD-OCT. Zoom and
rotation of the 3D view as well as scrolling through B-scans and
moving the SLO image and SD-OCT scan together with the
microperimetry layer are supported. The software tool has been
developed as WPF application (Microsoft Windows Presentation
Foundation) using the Microsoft. NET Framework 3.5 sp1. The
OCT 3D view is implemented as WPF 3D model, whereas B-
scans, cSLO image and the microperimetry layers are displayed as
textured 3D planes.
The software also allows for the alignment of B-scans using
retinal pigment epithelium segmentation data which can be loaded
from the VOL file as well as extracted automatically using a
Matlab (The MathWorks, Inc) script that processes the B-scans.
Segmentation borders are mathematically represented as bsplines
that can be altered manually in case of segmentation errors.
Correlation of retinal sensitivity and outer retinal
thickness
Correlation between sensitivity assessed by microperimetry and
thickness of the outer retina was tested within an area of 363
degrees (nine testing points) centred 2 degrees temporal to the
foveal centre. This area was selected due to its vulnerability to
functional damage in patients with macular telangiectasia type 2
[11]. The outer retinal thickness was measured between the inner
border of the retinal pigment epithelial layer and the border
between outer nuclear layer and outer plexiform layer. Thus, the
measurement reflects all photoreceptor layers (outer nuclear layer,
inner and outer segments) on the OCT images. The thickness was
always measured in direct topographic correlation to the lowest
sensitivity value of the nine testing points within the above defined
area. If several testing points qualified with an equally low value,
the measurement was performed at the location of most profound
neurosensory pathology. Severely disrupted outer retinal mor-
phology in a subset of patients introduces some noise in image
analysis as previously discussed [41]. The outer retinal thickness
was set as zero in areas where the outer plexiform layer was
directly attached to the retinal pigment epithelium layer or when
hyporeflective spaces or intraretinal pigment migration extended
throughout the entire photoreceptor layer. To analyze the
relationship between the outer retinal thickness and retinal
sensitivity a two-sided Fisher exact test of significance was
performed. This statistical test was chosen because of a clustering
of data points at zero. To investigate if the correlation is still
significant when this subset of data points is excluded a
Spearman’s rank correlation coefficient was calculated as a sub-
analysis of the correlation of outer retinal thickness and retinal
function.
Recording of three-dimensional SD-OCT volume scans
In patients with macular telangiectasia type 2, three-dimen-
sional volume scans were recorded using the following settings: a
scan pattern consisting of 61 equally spaced horizontal B-scans
(768 A-scans per 30u, resulting in a lateral digital resolution of
11 mm/pixel) covered an area of 30 (horizontally) 625 (vertically)
degrees centered on the foveola. In addition, as exemplified in
the videos, individual patients were examined using a denser SD-
OCT scanning pattern. This encompassed 97 equally spaced
horizontal scans covering an area of 15 degrees horizontally 610
degrees vertically, resulting in about 30 mm distance between
individual horizontal scans. Here, each B-scan consisted of 768
A-scans per 15u, resulting in a lateral digital resolution of 5 mm/
pixel.
Assessment of fixation stability
Fundus controlled fixation testing with dilated pupils was also
performed with the MP1 prior to microperimetry and retinal
imaging. A suprathreshold 2u red cross was used as fixation target
against a white background with a luminance of 1.27 cd/m2. The
room was dark during examination. Fixation stability was assessed
over a period of 30 seconds and calculated as bivariate contour
ellipse area (BCEA), within which the centre of the target was
imaged 68% of the time. The fixation data were further evaluated
to determine if there were multiple fixation loci (preferred retinal
loci, PRLs) using a kernal density estimator technique described by
Crossland et al. [42]. Data were only recorded whilst the eye
tracking was active. Thus, no data were recorded whilst blinking
or loss of tracking. Due to the possible dependency between the
subject’s two eyes only right eyes were included in the analysis. A
two-tailed unpaired t-test was used to detect a difference in
fixations stability between the patients’ group and a group of 15
healthy normal controls.
Prospective interventional clinical trial (RAMA trial)
Based on short-term observations after intravitreal application of
the vascular endothelial growth factor (VEGF) inhibitor bevacizu-
mab in patients with non-proliferative macular telangiectasia type 2
[43], a prospective interventional clinical trial was initiated to study
the effectiveness and safety of intravitreal VEGF-inhibition using
ranibizumab (ClinicalTrials.gov number, NCT00504400; Paul-
Ehrlich-Institut/EudraCT-EMEA, CRFB002ADE04; RAMA tri-
al). Ranibizumab is an antigen binding region fragment of a
recombinant, humanized monoclonal antibody which was recently
approvedbythe Food andDrug Administrationforthetreatmentof
neovascular age-related macular degeneration. One eye of each
patient (n=10) with a non-proliferative disease stage received a
monthly intravitreal injection of 0.5 mg ranibizumab for 12
months. The primary endpoint was the change in best-corrected
distancevisualacuityafterone yearcomparedtobaseline(measured
using ETDRS distance visual acuity charts). Secondary endpoints
included the change in retinal sensitivity measured with micro-
perimetry, the change in retinal thickness assessed by SD-OCT and
the change in parafoveal leakage assessed by fluorescein angiogra-
phy. For the analysis of the change in retinal sensitivity, nine testing
points covering an area of 363 degrees centred 2 degrees temporal
to the foveal centre were analyzed. This area was selected due to its
vulnerability to functional damage in patients with macular
telangiectasia type 2 [11]. Changes in visual acuity and retinal
sensitivity between baseline and the one year follow-up were
compared using the two-tailed paired t-test. Mean visual acuity
showed a transient increase in the study eye. However, after 12
months of treatment there was no significant change of visual acuity
compared to baseline or compared to the fellow eye (see Results).
There was a decrease of vascular pathology and leakage detectable
on fluorescein angiography (as visualized in Fig. 5: cf. panels b and c
with a). This was accompanied by a topographically related
significant reduction in macular thickness.
Macula: Structure and Function
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Figure S1 Fixation stability inmacular telangiectasia type2 inthe
presence of profound paracentral retinal sensitivity loss. Illustration
of fixation stability in the same patient as presented in Fig. 5 at the
12 month follow up examination. Although there is a deep
paracentral scotoma (Fig. 5, right column), fixation is very stable.
This is a typical finding in patients with macular telangiectasia type
2 as reported recently (4).The red cross with a diameter of 2 degrees
of visual angle represents the fixation target. The blue dots visualize
fixation at individual time points (shifts in the horizontal, X, and
vertical, Y, direction relative to a reference frame) during the
examination time of 30 seconds. The spread of the fixation dots
centered on the baricenter represents the patient’s eye movements.
The graph below shows the distances (in degrees) between the
fixation points (25 points/sec) and their baricenter vs. time.
Found at: doi:10.1371/journal.pone.0012864.s001 (2.43 MB TIF)
Figure S2 Morphological effect of anti-VEGF therapy in
macular telangiectasia type 2. Late phase fluorescein angiography
in a patient with macular telangiectasia type 2 at baseline (left
panel) and one month after the first intravitreal injection of 1.25
mg ranibizumab (middle panel). The right panels show the
corresponding SD-OCT analysis. Green colour coding marks an
area of retinal thinning. The right lower panel depicts the
thickness profile along the white dashed line in the left panel. Anti-
VEGF therapy has a clear morphological effect in macular
telangiectasia type 2: There is a decrease in late phase
angiographic leakage that is topographically related to a decrease
in retinal thickness.
Found at: doi:10.1371/journal.pone.0012864.s002 (6.19 MB TIF)
Video S1 Structure function correlation in a normal subject.
Found at: doi:10.1371/journal.pone.0012864.s003 (9.44 MB
MOV)
Video S2 Structure function correlation in a patient with
macular telangiectasia.
Found at: doi:10.1371/journal.pone.0012864.s004 (8.72 MB
MOV)
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